Detalles de la búsqueda
1.
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials.
CNS Spectr
; 20(2): 148-56, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24902007
2.
A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder.
J Clin Psychopharmacol
; 34(1): 47-56, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24172209
3.
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.
J Psychiatry Neurosci
; 39(1): 40-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24144196
4.
An evaluation of treatment response and remission definitions in adult obsessive-compulsive disorder: A systematic review and individual-patient data meta-analysis.
J Psychiatr Res
; 173: 387-397, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598877
5.
Spirituality, schizophrenia, and state hospitals: program description and characteristics of self-selected attendees of a spirituality therapeutic group.
Psychiatr Q
; 81(4): 285-92, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20407829
6.
Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
J Psychiatr Res
; 43(6): 664-70, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19046587
7.
Telomerase levels in schizophrenia: a preliminary study.
Schizophr Res
; 106(2-3): 242-7, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18829263
8.
Spirituality matters: creating a time and place for hope.
Psychiatr Rehabil J
; 30(4): 307-10, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17458455
9.
Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature.
Clin Pharmacokinet
; 56(5): 493-503, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27722855
10.
Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study.
Psychopharmacology (Berl)
; 234(2): 199-209, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807604
11.
Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.
Int Clin Psychopharmacol
; 31(2): 100-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26584326
12.
Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence.
Neurol Ther
; 4(2): 81-91, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26662360
13.
Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.
Prim Care Companion CNS Disord
; 17(3)2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26644957
14.
Evaluation of Cytochrome P450 (CYP) 3A4-Based Interactions of Levomilnacipran with Ketoconazole, Carbamazepine or Alprazolam in Healthy Subjects.
Clin Drug Investig
; 35(10): 601-12, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26315684
15.
Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans.
Drug Des Devel Ther
; 9: 3293-300, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26150701
16.
Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition.
Clin Ther
; 37(9): 2059-70, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26256429
17.
Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
J Affect Disord
; 174: 296-302, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25532076
18.
A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder.
J Drug Assess
; 3(1): 10-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-27536449
19.
Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials.
Int Clin Psychopharmacol
; 29(4): 197-205, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24667487
20.
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.
Innov Clin Neurosci
; 11(1-2): 10-22, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24653937